Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export

被引:458
|
作者
Brown, Caitlin W. [1 ]
Amante, John J. [1 ]
Chhoy, Peter [1 ]
Elaimy, Ameer L. [1 ]
Liu, Haibo [1 ]
Zhu, Lihua Julie [1 ]
Baer, Christina E. [2 ,3 ]
Dixon, Scott J. [4 ]
Mercurio, Arthur M. [1 ]
机构
[1] Univ Massachusetts, Dept Mol Cell & Canc Biol, Med Sch, Worcester, MA 01605 USA
[2] Univ Massachusetts, Dept Microbiol & Physiol Syst, Med Sch, Worcester, MA 01605 USA
[3] Univ Massachusetts, Sanderson Ctr Opt Examinat, Med Sch, Worcester, MA 01605 USA
[4] Stanford Univ, Dept Biol, Stanford, CA 94305 USA
关键词
CELL-DEATH; CANCER-CELLS; RECEPTOR; FORM; PROTRUSIONS; TRANSFERRIN; PATHWAY;
D O I
10.1016/j.devcel.2019.10.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ferroptosis, regulated cell death characterized by the iron-dependent accumulation of lethal lipid reactive oxygen species, contributes to tissue homeostasis and numerous pathologies, and it may be exploited for therapy. Cells differ in their sensitivity to ferroptosis, however, and a key challenge is to understand mechanisms that contribute to resistance. Using RNA-seq to identify genes that contribute to ferroptosis resistance, we discovered that pro-ferroptotic stimuli, including inhibition of the lipid hydroperoxidase GPX4 and detachment from the extracellular matrix, induce expression of prominin2, a pentaspanin protein implicated in regulation of lipid dynamics. Prominin2 facilitates ferroptosis resistance in mammary epithelial and breast carcinoma cells. Mechanistically, prominin2 promotes the formation of ferritin-containing multivesicular bodies (MVBs) and exosomes that transport iron out of the cell, inhibiting ferroptosis. These findings reveal that ferroptosis resistance can be driven by a prominin2-MVB-exosome-ferritin pathway and have broad implications for iron homeostasis, intracellular trafficking, and cancer.
引用
收藏
页码:575 / +
页数:16
相关论文
共 50 条
  • [31] A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma
    Miao, Zong
    Xu, Lei
    Gu, Wei
    Ren, Yimin
    Li, Rong
    Zhang, Shuai
    Chen, Chao
    Wang, Hongxiang
    Ji, Jing
    Chen, Juxiang
    REDOX BIOLOGY, 2024, 73
  • [32] TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/ SCD1 pathway
    Liu, Min-Yao
    Li, Hong-Ming
    Wang, Xin-Yu
    Xia, Ran
    Li, Xiang
    Ma, Yu-Jie
    Wang, Miao
    Zhang, Hong-Sheng
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 182 : 219 - 231
  • [33] Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
    Viveiros, Andre
    Panzer, Marlene
    Baumgartner, Nadja
    Schaefer, Benedikt
    Finkenstedt, Armin
    Henninger, Benjamin
    Theurl, Igor
    Nachbaur, Karin
    Weiss, Guenter
    Haubner, Roland
    Decristoforo, Clemens
    Tilg, Herbert
    Zoller, Heinz
    LIVER INTERNATIONAL, 2020, 40 (08) : 1941 - 1951
  • [34] MS4A15 drives ferroptosis resistance through calcium-restricted lipid remodeling
    Shan Xin
    Constanze Mueller
    Susanne Pfeiffer
    Vanessa A. N. Kraft
    Juliane Merl-Pham
    Xuanwen Bao
    Regina Feederle
    Xiang Jin
    Stefanie M. Hauck
    Philippe Schmitt-Kopplin
    Joel A. Schick
    Cell Death & Differentiation, 2022, 29 : 670 - 686
  • [35] Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells
    Battaglia, Anna Martina
    Sacco, Alessandro
    Perrotta, Ida Daniela
    Faniello, Maria Concetta
    Scalise, Mariangela
    Torella, Daniele
    Levi, Sonia
    Costanzo, Francesco
    Biamonte, Flavia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Asiatic acid ameliorates doxorubicin-induced cardiotoxicity by promoting FPN-mediated iron export and inhibiting ferroptosis
    Wu, Lin
    Wang, Li-tao
    Du, Yu-xin
    Zhang, Ying-mei
    Ren, Jun
    ACTA PHARMACOLOGICA SINICA, 2025, 46 (01) : 81 - 95
  • [37] 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer
    Chen, Youming
    Jiang, Zuli
    Zhang, Chenxing
    Zhang, Lindong
    Chen, Huanxiang
    Xiao, Nan
    Bai, Lu
    Liu, Hongyang
    Wan, Junhu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (04)
  • [38] Voltage-Dependent Anion Channel 2 ( VDAC2) Drives Rituximab Resistance Via Inhibiting Ferroptosis in Diffuse Large B Cell Lymphoma
    Li, Qiong
    Xia, Jing
    Li, Xinlei
    Zhang, Xi
    Rao, Jun
    BLOOD, 2023, 142
  • [39] Inhibiting iron-sulfur cluster export activates ferroptosis and potentiates cisplatin response in pediatric group 3 medulloblastomas
    Mahapatra, Sidharth
    Kanchan, Ranjana K.
    Doss, David
    Alsafwani, Zahraa W.
    Khan, Parvez
    Nasser, Mohd W.
    Batra, Surinder K.
    CANCER RESEARCH, 2024, 84 (17)
  • [40] NFE2L2 and ferroptosis resistance in cancer therapy
    Tang, Daolin
    Kang, Rui
    CANCER DRUG RESISTANCE, 2024, 7